Concepedia

José Luis Pérez

JL

Statistics

Publications

55

Citations

2.9K

H-Index

29

Active since

1997

Affiliations

Research Institute of Health Sciences(Current)

Mathematics Research Center

Hospital Universitario Son Dureta

Kansai University

Finlay Institute

José Luis Pérez is an author at Research Institute of Health Sciences specializing in life sciences, microbiology, and antibiotic resistance.

ORCID

Publications per year

1997–2023

55

Publications

55

Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa

Pablo A. Fraile-Ribot, Gabriel Cabot, Xavier Mulet et al. · Journal of Antimicrobial Chemotherapy · 2017 · 203 citations · Full text

, , +17

Molecular Epidemiology and Mechanisms of Carbapenem Resistance in <i>Pseudomonas aeruginosa</i> Isolates from Spanish Hospitals

Olivia Gutiérrez, Carlos Juan, Emilia Cercenado et al. · Antimicrobial Agents and Chemotherapy · 2007 · 184 citations

, , +17

Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction in<i>Pseudomonas aeruginosa</i>Clinical Strains

Carlos Juan, María D. Macià, Olivia Gutiérrez et al. · Antimicrobial Agents and Chemotherapy · 2005 · 170 citations · Full text

, , +17

Stepwise Upregulation of the<i>Pseudomonas aeruginosa</i>Chromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD Homologues

Carlos Juan, Bartolomé Moyá, José Luis Pérez et al. · Antimicrobial Agents and Chemotherapy · 2006 · 165 citations · Full text

, , +17

Characterization of a Large Outbreak by CTX-M-1-Producing <i>Klebsiella pneumoniae</i> and Mechanisms Leading to In Vivo Carbapenem Resistance Development

A. Mena, Virginia Plasencia, Laura Molina García et al. · Journal of Clinical Microbiology · 2006 · 144 citations · Full text

, , +17

1–5 of 55